Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for Exercise-triggered Ventricular Ectopy in CPVT
NCT02927223Completed
- Sponsor
- Vanderbilt University
- Start
- Oct 2016
- Primary completion
- Feb 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of atropine in catecholaminergic polymorphic ventricular tachycardia (CPVT), sponsored by Vanderbilt University. Primary endpoint: Number of Ventricular Ectopic Beats Recorded During Exercise (and Recovery) at 20 minutes. Started Oct 2016; status: completed.
02
Drugs
atropine
03
Conditions
catecholaminergic polymorphic ventricular tachycardia (CPVT)
Beyond the preview
Go deeper on NCT02927223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927223.